N-Glycans carried by Tamm-Horsfall glycoprotein have a crucial role in the defense against urinary tract diseases

Glycoconjugate Journal

Volumn 22, Issue 7-9, 2005, Pages 383-394

  Serafini Cessi, Franca ^a,b   Monti, Angela ^a   Cavallone, Daniela ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Dept Experimental Pathology ^*  (Italy)

Author keywords

E.coli infections; Sda antigen; Tamm Horsfall protein; Urolithiasis; Uromodulin

Indexed keywords

CALCIUM OXALATE; CALCIUM PHOSPHATE; CARBOHYDRATE ANTIGEN; GLYCAN DERIVATIVE; LIGAND; MANNOSE; OLIGOSACCHARIDE; PENTASACCHARIDE; POLYMER; TAMM HORSFALL GLYCOPROTEIN;

BACTERIAL COLONIZATION; CARBOHYDRATE ANALYSIS; CRYSTAL; ESCHERICHIA COLI; FIMBRIA; GELATION; HUMAN; IMMUNITY; NEPHROLITHIASIS; NEPHRON; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN POLYMERIZATION; PROTEIN URINE LEVEL; SHORT SURVEY; SIALYLATION; URINARY TRACT DISEASE; URINARY TRACT INFECTION; URINE;

ANIMALS; BLOOD GROUP ANTIGENS; CARBOHYDRATE SEQUENCE; ESCHERICHIA COLI INFECTIONS; GELS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; KIDNEY CALCULI; MANNANS; MICE; MOLECULAR SEQUENCE DATA; MUCOPROTEINS; N-ACETYLGALACTOSAMINYLTRANSFERASES; N-ACETYLNEURAMINIC ACID; POLYSACCHARIDES; UROLOGIC DISEASES;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 28344455118     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-005-2142-z     Document Type: Short Survey

References (129)

1. Tamm I, Horsfall FL, Characterization and separation of an inhibitor of viral Hemagglutination present in urine, Proc Soc Exp Biol Med 74, 108-14 (1950).
2. Gottschalk A, Carbohydrate residue of a urine mucoprotein inhibiting Influenza virus haemagglutination, Nature 170, 662-3 (1952).
3. Odin L, Carbohydrate residue of a urine mucoprotein inhibiting Influenza virus haemagglutination, Nature 170, 663-4 (1952).
4. Grant AM, Neuberger A, The development of a radioimmunoassay for the measurement of urinary Tamm-Horsfall glycoprotein in the presence of sodium dodecyl sulphate, Clinicalscience 44, 163-79 (1973).
5. Hoyer JR, Sisson SP, Vernier RL, Tamm-Horsfall glycoprotein: ultrastructural immunoperoxidase localization in rat kidney, Lab Invest 41, 168-73 (1979).
6. Sikri KL, Foster CL, Bloomfield FJ, Marshall RD, Localization by immunofluorescence and by light- and electron-microscopic immunoperoxidase techniques of Tamm-Horsfall glycoprotein in adult hamster kidney, Biochem J 181, 525-32 (1979).
7. Sikri KL, Foster CL, MacHugh N, Marshall RD, Localization of Tamm-Horsfall glycoprotein in the human kidney using immunofluorescence and immuno-electron microscopical techniques, J Anat 132, 597-605 (1981).
8. Bachmann S, Metzger R, Bunnemann B, Tamm-Horsfall protein-mRNA synthesis is localized to the thick ascending limb of Henle's loop in rat kidney, Histochemistry 94, 517-23 (1990).
9. Gokhale JA, Glenton PA, Khan SR, Characterization of Tamm-Horsfall protein in a rat nephrolithiasis model, J Urol 166, 1492-7 (2001).
10. a antigen, Giornale Italiano di Nefrologia 4, 418-24 (2001). (in Italian)
11. Pennica D, Kohr WJ, Kuang WJ, Glaister D, Aggarwal BB, Chen EY, Goeddel DV, Identification of human uromodulin as the Tamm-Horsfall urinary glycoprotein, Science 236, 83-8 (1987).
12. Rindler MJ, Naik SS, Li N, Hoops TC, Peraldi MN, Uromodulin (Tamm-Horsfall glycoprotein/uromucoid) is a phosphatidylinositol-linked membrane protein, J Biol Chem 265, 20784-9 (1990).
13. Malagolini N, Cavallone D, Serafini-Cessi F, Intracellular transport, cell-surface exposure and release of recombinant Tamm-Horsfall glycoprotein, Kidney Int 52, 1340-50 (1997).
14. Kreft B, Jabs WJ, Laskay T, Klinger M, Solbach W, Kumar S, van Zandbergen G, Polarized expression of Tamm-Horsfall protein by renal tubular epithelial cells activates human granulocytes, Infect Immun 70, 2650-6 (2002).
15. Cavallone D, Malagolini N, Serafini-Cessi F, Mechanism of release of urinary Tamm-Horsfall glycoprotein from the kidney GPI-anchored counterpart, Biochem Biophys Res Commun 280, 110-14 (2001).
16. Fukuoka S, Kobayashi KI, Analysis of the C-terminal structure of urinary Tamm-Horsfall protein reveals that the release of glycosyl phosphatidylinositol- anchored counterpart from the kidney occurs by phenylalanine-specific proteolysis, Biochem Biophys Res Commun 289, 1044-8 (2001).
17. Fletcher AP, Neuberger A, Ratcliffe WA, Tamm-Horsfall urinary glycoprotein. The subunit structure, Biochem J 120, 425-32 (1970).
18. Fletcher AP, Neuberger A, Ratcliffe WA, Tamm-Horsfall urinary glycoprotein. The chemical composition, Biochem J 120, 417-24 (1970).
19. Dunstan DR, Grant AMS, Marshall RD, Neuberger A, A protein immunologically similar to Tamm-Horsfall glycoprotein, produced by cultured baby hamster kidney cells, Proc Soc Lond (B Biol Sci) 186, 297-316 (1974).
20. Williams J, Marshall RD, van Halbeek H, and Vliegenthart JFG, Structural analysis of the carbohydrate moieties of human Tamm-Horsfall glycoprotein, Carbohydr Res 134, 141-55 (1984).
21. Hard K, Van Zadelhoof G , Moonen P, Kamerling JP, Vliegenthart JFG, The Asn-linked carbohydrate chains of human Tamm-Horsfall glycoprotein of one male, Eur J Biochem 209, 895-915 (1992).
22. van Rooijen JJM, Kamerling JP, Vliegenthart JFG, Sulfated di-, tri- and tetraantennary N-glycans in human Tamm-Horsfall glycoprotein, Eur J Biochem 256, 471-87 (1998).
23. van Rooijen JJM, Kamerling JP, Vliegenthart JFG, The abundance of additional N-acetyllactosamine units in N-linked tetraantennary oligosaccharides of human Tamm-Horsfall glycoprotein is a donor-specific feature, Glycobiology 8, 1065-75 (1998).
24. van Rooijen JJM, Voskamp AF, Kamerling JP, Vliegenthart JFG, Glycosylation sites and site-specific glycosylation in Tamm-Horsfall glycoprotein, Glycobiology 9, 21-30 (1999).
25. van Rooijen JJM, Hermentin P, Kamerling JR Vliegenthart JFG, The patterns of the complex- and oligomannose-type glycans of uromodulin (Tamm-Horsfall glycoprotein) in the course of pregnancy, Glycoconjugate J 18, 539-46 (2001).
26. Serafini-Cessi F, Malagolini N, Dall'Olio F, A tetraantennary glycopeptide from human Tamm-Horsfall glycoprotein inhibits agglutination of desialylated erythrocytes induced by leucoagglutinin, Biosci Rep 4, 973-8 (1984).
27. Serafini-Cessi F, Franceschi C, Sperti S, Specific interaction of human Tamm-Horsfall glycoprotein with leucoagglutinin, a lectin from Phaseolus vulgaris (Red kidney bean), Biochem J 183, 381-8 (1979).
28. Abbondanza A, Franceschi C, Licastro F, Serafini-Cessi F, Properties of glycopeptide isolated from human Tamm-Horsfall glycoprotein, Biochem J 187, 525-8 (1980).
29. Serafini-Cessi F, Dall'Olio F, Malagolini N, High-mannose oligosaccharides from human Tamm-Horsfall glycoprotein, Biosci Rep 4, 269-74 (1984).
30. Dall'Olio F, de Kanter FJJ, van den Eijnden DH, Serafini-Cessi F, Structural analysis of the preponderant high-mannose oligosaccharides of human Tamm-Horsfall glycoprotein, Carbohydr Res 178, 327-32 (1988).
31. Nielsen S, Smith BL, Christensen EI, Knepper MA, Agre P, CHIP28 water channels are localized in constitutively water-permeable segments of the nephron, J Cell Biol 120, 371-83 (1993).
32. Hannan LA, Edidin M, Traffic, polarity, and detergent solubility of a glycosylphosphatidylinositol-anchored protein after LDL-deprivation of MDCK cells, J Cell Biol 133, 1265-76 (1996).
33. Muchmore AV, Decker JM, Uromodulin: a unique 85-kilodalton immunosuppressive glycoprotein isolated from urine of pregnant women, Science 229, 479-81 (1985).
34. Moonen P, Gaffner R, Wingfield P, Native cytokines do not bind to uromodulin (Tamm-Horsfall glycoprotein), FEBS Lett 226, 314-8 (1988).
35. Serafini-Cessi F, Malagolini N, Cavallone D, Tamm-Horsfall glycoprotein: Biology and clinical relevance, Am J Kidney Dis 42, 658-76 (2003).
36. Pak J, Pu Y, Zhang ZT, Hasty DL, Wu XR, Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors, J Biol Chem 276, 9924-30 (2001).
37. Cavallone D, Malagolini N, Monti A, Wu XR, Serafini-Cessi F, Variation of high mannose chains of Tamm-Horsfall glycoprotein confers differential binding to type 1-fimbriated Escherichia coli, J Biol Chem 279, 216-22 (2004).
38. Bates JM, Raffi HM, Prasadan K, Mascarenhas R, Laszik Z, Maeda N, Hultgren SJ, Kumar S, Tamm-Horsfall protein knockout mice are more prone to urinary tract infection, Kidney Int 65, 791-7 (2004).
39. Mo L, Zhu XH, Huang HY, Hasty DL, Wu XR, Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli, Am J Physiol Renal Physiol 286, F795-802 (2004).
40. Khan SR, Kok DJ, Modulators of urinary stone formation, Front Biosc 9, 1450-82 (2004).
41. Mo L, Huang HY, Zhu XH, Shapiro E, Hasty DL, Wu XR, Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation, Kidney Int 66, 1159-66 (2004).
42. Wangsiripaisan A, Gengaro PE, Edelstein CL, Schrier RW, Role of polymeric Tamm-Horsfall protein in cast formation: oligosaccharide and tabular fluid ions, Kidney Int 59, 932-40 (2001).
43. Huang ZQ, Sanders PW, Biochemical interaction between Tamm-Horsfall glycoprotein and Ig light chains in the pathogenesis of cast nephropathy, Lab Invest 73, 810-17 (1995).
44. Mulvey MA, Adhesion and entry of uropathogenic Escherichia coli, Cell Microbiol 4, 257-71 (2002).
45. Barnett BJ, Stephens DS, Urinary tract infection: an overview, Am J Med Sci 314, 245-9 (1997).
46. Ofek I, Mirelman D, Sharon N, Aderence of Escherichia coli to microbal cells mediated by mannose receptors, Nature 265, 623-5 (1977).
47. Aronson M, Medalia O, Schory D, Mirelman D, Sharon N, Ofek I, Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl α-D-mannopyranoside, J Infect Dis 139, 329-32 (1979).
48. Hanson MS, Brinton CC, Identification and characterization of E. coli type-1 pilus tip adhesion protein Nature 332, 265-8 (1988).
49. Martinez JJ, Mulvey MA, Schilling JD, Pinker JS, Hultgren SJ, Type 1 pilus-mediated bacterial invasion of bladder epithelial cells, EMBO J 19, 2803-12 (2000).
50. Sokurenko EV, Courtney HS, Maslow J, Siitonen A, Hasty DL, Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes, J Bacteriol 177, 3680-6 (1995).
51. Sokurenko EV, Chesnokova V, Doyle RJ, Hasty DL, Diversity of the Escherichia coli type 1 fimbrial lectin, Differential binding to mannosides and uroepithelial cells, J Biol Chem 272, 17880-6 (1997).
52. Sokurenko EV, Chesnokova V, Dykhuizen DE, Ofek I, Wu XR, Krogfelt KA, Struve C, Schembri MA, Hasty DE, Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin, Proc Natl Acad Sci USA 95, 8922-6 (1998).
53. Wu XR, Sun TT, Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell-surface glycoprotein, J Cell Sci 106, 31-43 (1993).
54. Malagolini N, Cavallone D, Wu XR, Serafini-Cessi F, Terminal glycosylation of bovine uroplakin III, One of the major integral-membrane glycoproteins of mammalian bladder, Biochem Biophys Acta, 1475, 231-7 (2000).
55. Wu XR, Lin JH, Walz T, Haner M, Yu J, Aebi U, Sun TT, Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins, J Biol Chem 269, 13716-24 (1994).
56. Wu XR, Medina JJ, Sun TT, Selective interactions of UP Ia and UP Ib, two members of the transmembrane 4 superfamily, with distinct single transmembrane-domained proteins in differentiated urothelial cells, J Biol Chem 270, 29752-9 (1995).
57. Wu XR, Sun TT, Medina JJ, In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections, Proc Natl Acad Sci USA 93, 9630-5 (1996).
58. Ikaheimo R, Siitonen A, Heiskanen T, Karkkainen U, Kuosmanen P, Lipponen P, Makela PH, Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women, Clin Infect Dis 22, 91-9 (1996).
59. Orskov I, Ferencz A, Orskov F, Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli, Lancet 1, 887 (1980).
60. Parkkinen J, Virkola R, Korhonen TK, Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins, Infect Immun 56, 2623-30 (1988).
61. Reinhart HH, Obedeanu N, Sobel JD, Quantitation of Tamm-Horsfall protein binding to uropathogenic Escherichia coli and lectins, J Infect Dis 162, 1335-40 (1990).
62. Benting JH, Rietveld AG, Simons K, N-glycans mediate the apical sorting of a GPI-anchored, raft associated protein in Madin-Darby canine kidney cells, J Cell Biol 146, 313-20 (1999).
63. Sherblom AP, Smagula RM, High-mannose chains of mammalian glycoproteins, Methods Mol Biol 14, 143-9 (1993).
64. Serafini-Cessi F, Malagolini N, Hoops TC, Rindler MJ, Biosynthesis and oligosaccharide processing of human Tamm-Horsfall glycoprotein permanently expressed in HeLa cells, Biochem Biophys Res Commun 194, 784-90 (1993).
65. Jovine L, Qi H, Williams Z, Litscher E, Wassarman PM, The ZP domain is a conserved module for polymerization of extracellular proteins, Nature Cell Biol 4, 457-61 (2000).
66. Firon N, Ofek I, Sharon N, Carbohydrate-binding sites of the mannose-specific fimbrial lectins of enterobacteria, Infect Immun 43, 1088-90 (1984).
67. Neeser JR, Koellreutter B, Wuersch P, Oligomannoside-type glycopeptides inhibiting adhesion of Escherichia coli strains mediated by type 1 pili: preparation of potent inhibitors from plant glycoproteins, Infect Immun 52, 428-36 (1986).
68. Sharon N, Bacterial lectins, cell-cell recognition and infectious disease, FEBS Lett 217, 145-57 (1987).
69. Kuriyama SM, Silverblatt FJ, Effect of Tamm-Horsfall urinary glycoprotein on phagocytosis and killing of type I-fimbriated Escherichia coli, Infect Immun 51, 193-8 (1986).
70. Hart TC, Gorry MC, Hart PS, Woodard AS, Shihabi Z, Sandhu J, Shirts B, Xu L, Zhu H, Barmada MM, Bleyer AJ, Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy, J Med Genet 39, 882-92 (2002).
71. Wolf MT, Mucha BE, Attanasio M, Zalewski I, Karle SM, Neumann HP, Rahman N, Bader B, Baldamus CA, Otto E, Witzgall R, Fuchshuber A, Hildebrandt F, Mutations of the Uromodulin gene in MCKD type 2 patients cluster in exon 4, which encodes three EGF-like domains, Kidney Int 64, 1580-7 (2003).
72. Kudo E, Kamatani N, Tezuka O, Taniguchi A, Yamanaka H, Yabe S, Osabe D, Shinohara S, Nomura K, Segawa M, Miyamoto T, Moritani M, Kunika K, Itakura M, Familial juvenile hyperuricemic nephropathy: Detection of mutations in the uromodulin gene in five Japanese families, Kidney Int 65, 1589-97 (2004).
73. Rampoldi L, Caridi G, Santon D, Boaretto F, Bernascone I, Lamorte G, Tardanico R, Dagnino M, Colussi G, Scolari F, Ghiggeri GM, Amoroso A, Casari G, Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics, Hum Mol Genet 12, 3369-84 (2003).
74. a, Vox Sang 13, 485-92 (1967).
75. a of a new blood group antibody, Vox Sang 13, 493-501 (1967).
76. a blood group antigen in tissues and body fluid, Vox Sang 19, 151-61 (1970).
77. a activity of Tamm and Horsfall urinary glycoprotein, Biochem Biophys Res Commun 93, 1132-9 (1980).
78. a-active pentasaccharide isolated from Tamm-Horsfall urinary glycoprotein, Biochem Biophys Res Commun 115, 625-31 (1983).
79. Donald ASR, Feeney J, Oligosaccharides obtained from a blood group Sd(a+) Tamm-Horsfall glycoprotein, an n.m.r. study, Biochem J 236, 821-8 (1986).
80. a and Cad antigen. Molecular basis of major human blood group antigen, edited by Cartron JP and Rouger F (Plenum Press, New York, 1995), vol 6, pp. 351-75.
81. Wu JH, Watkins WM, Chen CP, Song SC, Chow LP, Lin JY, Interaction of a human blood group Sd (a-) Tamm-Horsfall glycoprotein with applied lectins, FEBS Lett 384, 231-4 (1996).
82. Wu AM, Watkins WM, Chen CP, Song SC, Chow LP, Lin JY, Native and/or asialo-Tamm-Horsfall glycoproteins Sd(a+) are important receptors for Triticum vulgaris (wheat germ) agglutinin and for three toxic lectins (abrin-a, ricin and mistletoe toxic lectin-I), FEBS Lett 371, 32-4 (1995).
83. Wu AM, Watkins WM, Chen CP, Song SC, Chow LP, Lin JY, Native and asialo-Tamm-Horsfall glycoproteins as important ligands for the detection of GalNAcβ1→ and Galβ1→4GlcNAc active lectins, Biochem Biophys Res Commun 209 103-10 (1995).
84. Serafini-Cessi F, Dall'Olio F, Guinea-pig kidney β-N- acetylgalactosaminyl-transferase towards Tamm-Horsfall glycoprotein. Requirement of sialic acid in the acceptor for transferase activity, Biochem J 215, 483-9 (1983).
85. a antigen associated with Tamm-Horsfall glycoprotein, Carbohydr Res 151, 65-76 (1986).
86. a antigen and its biosynthetic enzyme: differentiation-dependent and onco-developmentally regulated expression, Trends Glycosci Glycotechnol 42, 279-95 (1996).
87. Smith PL, Lowe JB, Molecular cloning of a murine N-acetylgalactosamine transferase that determines expression of the T lymphocyte-specific CT oligosaccharide differentiation antigen, J Biol Chem 269, 15162-71 (1994).
88. Piller F, Blanchard D, Huet M, Cartron JP, Identification of a α-NeuAc-(2-3)- β-D-galactopyranosyl N-acetyl- β-D- galactopyranosyltransferase in human kidney, Carbohydr Res 149, 171-84 (1986).
89. a antigen in human large intestine and colorectal carcinomas, Cancer Res 49, 6466-70 (1989).
90. Serafini-Cessi F, Malagolini N, Dall'Olio F, Characterization and partial purification of β-N-acetyl-galactosaminyltransferase from urine of Sd(a+) individuals, Arch Biochem Biophys 266, 573-82 (1988).
91. Capon C, Maes E, Michalski JC, Leffler H, Kim YS, Sd(a)-antigen-like structures carried on core 3 are prominent features of glycans from the mucin of normal human descending colon, Biochem J 358, 657-64 (2001).
92. Robbe C, Capon C, Maes E, Rousset M, Zweibaum A, Zanetta JP, Michalski JC, Evidence of regio-specific glycosylation in human intestinal mucins: Presence of an acidic gradient along the intestinal tract, J Biol Chem 278, 46337-348 (2003).
93. Dall'Olio F, Malagolini N, Serafini-Cessi F, Tissue distribution and age-dependent expression of β-4-N-acetylgalactosaminyltransferase in guinea-pig, Biosci Rep 7, 925-32 (1987).
94. a antigen and of α2,6 sialyltransferase towards N-acetyllactosamine, Biochem J 270, 519-24 (1990).
95. Rohfritsch PF, Rinnbauer M, Vliegenthart JF, Kamerling JP, Donor specificity in the glycosylation of Tamm-Horsfall glycoprotein: Conservation of the Sd(a) determinant in pairs of twins, Glycobiology 14, 365-72 (2004).
96. Watkins WM, Greenwell P, Yates AD, Johnson PH, Regulation of expression of carbohydrate blood group antigens, Biochimie 70, 1597-611 (1988).
97. + and Escherichia coli to isolated intestinal epithelial cells, Infec Immunol 28, 298-300 (1980).
98. Hagberg L, Jodal U, Korhonen TK, Lidin-Janson G, Lindberg U, Svanborg Eden C, Adhesion, haemagglutination, and virulence of Escherichia coli causing urinary tract infection, Infect Immunol 31, 564-70 (1981).
99. Coe FL, Parks JH, Asplin JR, The pathogenesis and treatment of kidney stones, N Eng J Med 327, 1141-52 (1992).
100. Marangella M, Vitale C, Petrarulo M, Bagnis C, Bruno M, Ramello A, Renal stones: from metabolic to physicochemical abnormalities. How useful are inhibitors? J Nephrology 13(Suppl 3), S51-60 (2000).
101. Hess B, Nakagawa Y, Coe FL, Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins, Am J Physiol Renal Physiol 257, 99-106 (1989).
102. Nakagawa Y, Abram V, Kezdy FJ, Kaiser ET, Coe FL, Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine, J Biol Chem 258, 12594-600 (1983).
103. Worcester EM, Blumenthal SS, Beshensky AM, Lewand DL, The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin, J Bone Miner Res 7, 1029-36 (1992).
104. Shiraga H, Min W, VanDusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Neilson EG, et al, Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily, Proc Natl Acad Sci USA 89, 426-30 (1992).
105. Ryall RL, Grover PK, Stapleton AM, Barrell DK, Tang Y, Simpson RJ, The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro, Clin Sci 89, 533-41 (1995).
106. Hess B, Kok DJ, Nucleation, growth and aggregation of stone forming crystals. In Kidney Stones, Medical and Surgical Management, edited by Coe FL, Favus MJ, Fak CYC, Parks JH, Preminger GM (Lippincott-Raven Publishers, Philadelphia, 1996), pp. 3-32
107. Romero MC, Nocera S, Nesse AB, Decreased Tamm-Horsfall protein in lithiasic patients, Clin Biochem 30, 63-7 (1997).
108. Ganter K, Bongartz D, Hesse A, Tamm-Horsfall protein excretion and its relation to citrate in urine of stone-forming patients, Urology 53, 492-5 (1999).
109. Bichler KH, Mittermuller B, Strohmaier WL, Feil G, Eipper E, Excretion of Tamm-Horsfall protein in patients with uric acid stones, Urol Int 62, 87-92 (1999).
110. Schnierle P, A simple diagnostic method for the differentiation of Tamm-Horsfall glycoproteins from healthy probands and those from recurrent calcium oxalate renal stone formers, Experientia 51, 1068-72 (1995).
111. Boeve ER, Cao LC, De Bruijn WC, Robertson WG, Romijn JC, Schroder FH, Zeta potential distribution on calcium oxalate crystal and Tamm-Horsfall protein surface analyzed with Doppler electrophoretic light scattering, J Urol 152, 531-6 (1994).
112. Grover PK, and Resnick MI, Evidence for the presence of abnormal proteins in the urine of recurrent stone formers, J Urol 153, 1716-21 (1995).
113. Trewick AL, and Rumsby G, Isoelectric focusing of native urinary uromodulin (Tamm-Horsfall protein) shows no physicochemical differences between stone formers and non-stone formers, Urol Res 27, 250-4 (1999).
114. Marengo SR, Chen DH, Kaung HL, Resnick MI, Yang L, Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis, J Urol 167, 2192-7 (2002).
115. Hallson PC, Choong SK, Kasidas GP, Samuell CT, Effects of Tamm-Horsfall protein with normal and reduced sialic acid content upon the crystallization of calcium phosphate and calcium oxalate in human urine, Br J Urol 80, 533-38 (1997).
116. Chen WC, Lin HS, Chen HY, Shih CH, Li CW, Effects of Tamm-Horsfall protein and albumin on calcium oxalate crystallization and importance of sialic acids, Mol Urol 5, 1-5 (2001).
117. Wesson JA, Johnson RJ, Mazzali M, Beshensky AM, Stietz S, Giachelli C, Liaw L, Alpers CE, Couser WG, Kleinman JG, Hughes J, Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules, J Am Soc Nephrol 14, 139-47 (2003).
118. Lieske JC, Toback FG, Deganello S, Sialic acid-containing glycoproteins on renal cells determine nucleation of calcium oxalate dihydrate crystals, Kidney Int 60, 1784-91 (2001).
119. Verkoelen CF, van der Boom BG, Kok DJ, Romijn JC, Sialic acid and crystal binding, Kidney Int 57, 1072-82 (2000).
120. Bayer ME, An electron microscope examination of urinary mucoprotein and its interaction with influenza virus, J Cell Biol 21, 265-74 (1964).
121. Stevenson FK, Cleave AJ, Kent PW, The effect of ions on the viscometric and ultracentrifugal behaviour of Tamm-Horsfall glycoprotein, Biochim Biophys Acta 236, 59-66 (1971).
122. Wiggins RC, Uromucoid (Tamm-Horsfall glycoprotein) forms different polymeric arrangements on a filter surface under different physicochemical conditions, Clin Chim Acta 162, 329-40 (1987).
123. Tamm I, Bugher JC, Horsfall FL, Ultracentrifugation studies of a urinary mucoprotein which reacts with various viruses, J Biol Chem 212, 125-33 (1955).
124. McQueen EG, Composition of urinary casts, Lancet 1, 397-8 (1966).
125. Serafini-Cessi F, Bellabarba G, Malagolini N, Dall'Olio F, Rapid isolation of Tamm-Horsfall glycoprotein (uromodulin) from human urine, J Immunol Methods 120, 185-9 (1989).
126. Cavallone D, Malagolini N, Frascà GM, Stefoni S, Serafini-Cessi F, Salt precipitation method does not isolate to homogeneity Tamm-Horsfall glycoprotein from urine of proteinuric patients and pregnant women, Clin Biochem 35, 405-10 (2002).
127. Lynn KL, Marshall RD, Excretion of Tamm-Horsfall glycoprotein in renal disease, Clin Nephrol 22, 253-7 (1984).
128. Bleyer AJ, Hart TC, Shihabi Z, Robins V, Hoyer JR, Mutations in the uromodulin gene decrease urinary excretion of Tamm-Horsfall protein, Kidney Int 66, 974-7 (2004)..
129. Korhonen TK, Parkkinen J, Hacker J, Finne J, Pere A, Rhen M, Holthofer H, Binding of Escherichia coli S fimbriae to human kidney epithelium, Infect Immun 54, 322-7 (1986).